Double-Blind Comparison of Slow-Release 5-Aminosalicylateand Sulfasalazine in Remission Maintenance in Ulcerative Colitis

Gastroenterology

Volumn 95, Issue 6, 1988, Pages 1449-1453

  Mulder, Chris J J ^a,b,c,d   Tytgat, Guido N J ^a,b,c,d   Weterman, Irene T ^a,b,c,d   Dekker, Willem ^a,b,c,d   Blok, Paul ^a,b,c,d   Schrijver, Max ^a,b,c,d   Heide, Herbert V D ^a,b,c,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Elisabeth Gasthuis ^*  (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

5 aminosalicylic acid; 5 ASA; UC; ulcerative colitis

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE;

ANXIETY; BACKACHE; DRUG EFFICACY; ENDOSCOPY; ERYTHRODERMA; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REMISSION; SIDE EFFECT; ULCERATIVE COLITIS;

EID: 0024208726     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(88)80061-1     Document Type: Article

References (25)

1. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis
2. Controlled trial of sulphasalazine in the treatment of ulcerative colitis
3. Controlled trial of sulfasalazine in maintenance therapy of ulcerative colitis
4. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulfasalazine
5. Optimum dose of sulfasalazine for maintenance treatment in ulcerative colitis
6. Adverse reactions during salicylazosulphapyridine therapy and the relation with drug metabolism and acetylator phenotype
7. An experiment to determine the active therapeutic moiety of sulphasalazine
8. Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease
9. Effect of sulphapyridine, 5-aminosalicylic acid and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine
10. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid
11. Treatment of Crohn's disease with peroral 5-aminosalicylic acid
12. 5-Aminosalicylic acid (Pentasa) in enema form for the treatment of active ulcerative colitis
13. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial
14. A double-blind trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis
15. 5-Aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans
16. The influence of intestinal transit time on 5-ASA from Pentasa (abstr)
17. Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis
18. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid
19. Role of ileocolonoscopy in diagnosis and follow up of inflammatory bowel disease
20. Comparison of Beclomethasone-dipropionate and prednisolone-21-phosphate enemas in distal ulcerative colitis
21. A complication of SASP therapy: hair loss
22. 5-Aminosalicylic acid in the treatment of Crohn's disease
23. Steady-state kinetics of 5-aminosalicylic acid and sulphapyridine during sulfasalazine prophylaxis in ulcerative colitis
24. Pentasa in lieu of sulfasalazine